Health TidingsChai Discovery’s AI Models Identify Binders Across All GSK Targets Tested Chai Discovery’s AI Models Identify Binders Across All GSK Targets Tested Read Post »
Health TidingsDenifanstat Cuts Acne Lesions by 72% at 52 Weeks, With 57% Treatment Succes... Denifanstat Cuts Acne Lesions by 72% at 52 Weeks, With 57% Treatment Succes... Read Post »
Health TidingsMineralys Reports 46% Reaching SBP Target at Week 12 and 11.1 mmHg Reductio... Mineralys Reports 46% Reaching SBP Target at Week 12 and 11.1 mmHg Reductio... Read Post »
Health TidingsVir’s VIR-5500 Fast Track by FDA for Advanced Prostate Cancer Vir’s VIR-5500 Fast Track by FDA for Advanced Prostate Cancer Read Post »
Health TidingsGlaukos Reports 3.6 mmHg Added IOP Reduction With iDose TR During Cataract ... Glaukos Reports 3.6 mmHg Added IOP Reduction With iDose TR During Cataract ... Read Post »
Health TidingsLife Bio Reports Preliminary Visual Field Improvements for ER-100 Life Bio Reports Preliminary Visual Field Improvements for ER-100 Read Post »
Health Tidings Mergers & AcquisitionsViatris to Acquire Pacira for $1.65 Billion Viatris to Acquire Pacira for $1.65 Billion Read Post »
Health TidingsBiofrontera Submits sNDA to Expand Ameluz® PDT for Actinic Keratoses Beyon... Biofrontera Submits sNDA to Expand Ameluz® PDT for Actinic Keratoses Beyon... Read Post »
Health TidingsFDA Grants Orphan Drug Designation to vTv’ HPPD for Sickle Cell Disease FDA Grants Orphan Drug Designation to vTv’ HPPD for Sickle Cell Disease Read Post »
Health TidingsCullinan Advances CLN-049 Into Pivotal Phase 2 Study in Relapsed/Refractory... Cullinan Advances CLN-049 Into Pivotal Phase 2 Study in Relapsed/Refractory... Read Post »
Health TidingsFDA Fast Track Advances Development of PSV359 in FAP-Positive SFTs FDA Fast Track Advances Development of PSV359 in FAP-Positive SFTs Read Post »
Health TidingsMHRA Approves Catumaxomab for Cancer-Related Abdominal Fluid Build-Up MHRA Approves Catumaxomab for Cancer-Related Abdominal Fluid Build-Up Read Post »
Health TidingsNewron Evenamide Faces FDA Clinical Hold in ENIGMA-TRS 2 Trial Newron Evenamide Faces FDA Clinical Hold in ENIGMA-TRS 2 Trial Read Post »
Health TidingsAtsena’s ATSN-201 Shows Microperimetry and Visual Gains in X-Linked Retin... Atsena’s ATSN-201 Shows Microperimetry and Visual Gains in X-Linked Retin... Read Post »
Health TidingsPositive Phase 3 ARISE Results Support Potential NDA Path for Cerevance’s... Positive Phase 3 ARISE Results Support Potential NDA Path for Cerevance’s... Read Post »
Health TidingsRuvonoflast Plus Semaglutide Shows Greater HsCRP Reduction Ruvonoflast Plus Semaglutide Shows Greater HsCRP Reduction Read Post »
Health TidingsSurVaxM Shows Significant Survival Benefit in Patients Aged 65 and Under Wi... SurVaxM Shows Significant Survival Benefit in Patients Aged 65 and Under Wi... Read Post »
Health TidingsAbbVie’s Temab-A Receives Two Breakthrough Therapy Designations for CRC a... AbbVie’s Temab-A Receives Two Breakthrough Therapy Designations for CRC a... Read Post »
Health TidingsMatchpoint Raises $150 Million to Advance Oral T-Cell Modulator MPT-062 Matchpoint Raises $150 Million to Advance Oral T-Cell Modulator MPT-062 Read Post »
Health TidingsArrowhead Granted FDA STAR Entry for Plozasiran sNDA in sHTG Arrowhead Granted FDA STAR Entry for Plozasiran sNDA in sHTG Read Post »
Health TidingsFDA Supports Proposed Clinical Study of Bausch + Lomb’s BL1243 for Dry AM... FDA Supports Proposed Clinical Study of Bausch + Lomb’s BL1243 for Dry AM... Read Post »
Health TidingsKymaThera Raises $80M to Advance K-1728 PI3Kα Inhibitor KymaThera Raises $80M to Advance K-1728 PI3Kα Inhibitor Read Post »
Health TidingsEnliven Reaches FDA Alignment on Phase 3 ENABLE-2 Trial of Relcobatinib in ... Enliven Reaches FDA Alignment on Phase 3 ENABLE-2 Trial of Relcobatinib in ... Read Post »
Health TidingsOkogen Gets CDSCO Authorization to Advance Treyegen for Acute Infectious Co... Okogen Gets CDSCO Authorization to Advance Treyegen for Acute Infectious Co... Read Post »
Health TidingsForward Reports Positive Phase 1 Data for FT2109, Advances to Phase 2 in Rh... Forward Reports Positive Phase 1 Data for FT2109, Advances to Phase 2 in Rh... Read Post »
GenericsLupin Launches Formoflo-G MDI in India for COPD Triple Therapy Lupin Launches Formoflo-G MDI in India for COPD Triple Therapy Read Post »
Health TidingsBridgeBio Announces FDA Acceptance and Priority Review of NDA for Oral Infi... BridgeBio Announces FDA Acceptance and Priority Review of NDA for Oral Infi... Read Post »
Health TidingsViking Initiates VK2735 Oral Maintenance Trial in Patients with Obesity Viking Initiates VK2735 Oral Maintenance Trial in Patients with Obesity Read Post »
Health TidingsPreclinical Biotech Company RougeTx Launches with $58 Million Series A to A... Preclinical Biotech Company RougeTx Launches with $58 Million Series A to A... Read Post »
Health Tidings Mergers & AcquisitionsShionogi Plans $2 Billion Acquisition of IntraBio to Expand Rare Disease Po... Shionogi Plans $2 Billion Acquisition of IntraBio to Expand Rare Disease Po... Read Post »
Medical DevicesClick’s Motivista Receives FDA Clearance for Negative Symptoms of Schizop... Click’s Motivista Receives FDA Clearance for Negative Symptoms of Schizop... Read Post »
Health Tidings Mergers & AcquisitionsAlector Signs $1.27 Billion Genentech Deal for Parkinson’s Disease Therap... Alector Signs $1.27 Billion Genentech Deal for Parkinson’s Disease Therap... Read Post »
Health Tidings2026 Nobel Prize in Medicine Awarded for Optogenetics 2026 Nobel Prize in Medicine Awarded for Optogenetics Read Post »
Health TidingsCapricor Reports 76% Slower Upper Limb Decline After Deramiocel Switch in H... Capricor Reports 76% Slower Upper Limb Decline After Deramiocel Switch in H... Read Post »
Health Tidings Mergers & AcquisitionsCSL and Alentis Partner to Advance Lixudebart in Kidney and Liver Diseases CSL and Alentis Partner to Advance Lixudebart in Kidney and Liver Diseases Read Post »
Health TidingsBenitec Says FDA Requests Additional Data for BB-301 Pivotal Study in OPMD Benitec Says FDA Requests Additional Data for BB-301 Pivotal Study in OPMD Read Post »
Health TidingsSerum Institute of India’s HPV Vaccine CERVAVAC Receives WHO Prequali... Serum Institute of India’s HPV Vaccine CERVAVAC Receives WHO Prequali... Read Post »
Health TidingsStoke Therapeutics Advances Zorevunersen NDA Plan for Dravet Syndrome Stoke Therapeutics Advances Zorevunersen NDA Plan for Dravet Syndrome Read Post »
Health TidingsRezolute Receives FDA Recommendation for Type B Pre-BLA Meeting for Ersodet... Rezolute Receives FDA Recommendation for Type B Pre-BLA Meeting for Ersodet... Read Post »
Health TidingsRilzabrutinib Shows Haemoglobin Responses in Adults with Warm Autoimmune Rilzabrutinib Shows Haemoglobin Responses in Adults with Warm Autoimmune Read Post »
Health TidingsFDA Extends Novo Nordisk’s Denecimig Review Over Manufacturing Facility R... FDA Extends Novo Nordisk’s Denecimig Review Over Manufacturing Facility R... Read Post »
Health Tidings Mergers & AcquisitionsAbogen and Novartis Partner to Advance mRNA-Encoded T-Cell Engager ABO2203 Abogen and Novartis Partner to Advance mRNA-Encoded T-Cell Engager ABO2203 Read Post »
Health TidingsFoghorn Therapeutics and Lilly End FHD-909 Development After Phase 1 Review Foghorn Therapeutics and Lilly End FHD-909 Development After Phase 1 Review Read Post »
Health TidingsFILSPARI Achieves 75% Complete Proteinuria Remission in Phase 2 SPARTAN Stu... FILSPARI Achieves 75% Complete Proteinuria Remission in Phase 2 SPARTAN Stu... Read Post »
Health TidingsAstraZeneca, Daiichi Sankyo and Summit to Test Datroway–Ivonescimab in Ph... AstraZeneca, Daiichi Sankyo and Summit to Test Datroway–Ivonescimab in Ph... Read Post »
Health TidingsRezpegaldesleukin Shows Durable Responses Across Alopecia Areata and Atopic... Rezpegaldesleukin Shows Durable Responses Across Alopecia Areata and Atopic... Read Post »
Health TidingsLundbeck to Present MSA and Parkinson’s Disease Data at MDS 2026 Lundbeck to Present MSA and Parkinson’s Disease Data at MDS 2026 Read Post »
Health Tidings Mergers & AcquisitionsItalfarmaco, JCR Sign JR-141 Licensing Deal for Hunter Syndrome Italfarmaco, JCR Sign JR-141 Licensing Deal for Hunter Syndrome Read Post »
Health TidingsREMODEL Trial Identifies Potential Mechanisms of Semaglutide’s Kidney-Pro... REMODEL Trial Identifies Potential Mechanisms of Semaglutide’s Kidney-Pro... Read Post »
Health TidingsCullinan Initiates Zipalertinib NDA Under FDA RTOR Program for First-Line E... Cullinan Initiates Zipalertinib NDA Under FDA RTOR Program for First-Line E... Read Post »
